References
- Jemal A, Siegel R, Ward E, Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
- Marugame T, Yoshimi I. Comparison of cancer mortality (lung cancer) in five countries: France, Italy, Japan, UK and USA from the WHO Mortality Database (1960–2000). Jpn J Clin Oncol 2005;35:168–70.
- Marugame T, Mizuno S. Mortality trend of lung cancer in Japan: 1960–2000. Jpn J Clin Oncol 2003;33:148–9.
- Kiyohara C, Otsu A, Shirakawa T, Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 2002;37:241–56.
- Thorgeirsson TE, Geller F, Sulem P, A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638–42.
- Hung RJ, McKay JD, Gaborieau V, A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633–7.
- Amos CI, Wu X, Broderick P, Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616–22.
- Shiraishi K, Kohno T, Kunitoh H, Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis 2009;30:65–70.
- Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7–17.
- de Torres JP, Bastarrika G, Wisnivesky JP, Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 2007;132:1932–8.
- Wilson DO, Weissfeld JL, Balkan A, Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008;178:738–44.
- Matsushita H, Tanaka S, Saiki Y, Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995;45:925–32.
- Parimon T, Chien JW, Bryson CL, Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:712-19.
- Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007;87:1047–82.
- McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002;109:707–12.
- Wang Y, Kuan PJ, Xing C, Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 2009;84:52–9.
- Ewis AA, Kondo K, Dang F, Surfactant protein B gene variations and susceptibility to lung cancer in chromate workers. Am J Ind Med 2006;49:367–73.
- Sin DD, Man SF, McWilliams A, Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancer. Chest 2008;134:582–8.
- Ishii T, Hagiwara K, Kamio K, Involvement of surfactant protein D in emphysema revealed by genetic association study. Eur J Hum Genet 2012;20:230–5.
- Foreman MG, Kong X, Demeo DL, Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2011;44:316–22.
- National Heart, Lung, and Blood Institute. The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am Rev Respir Dis 1985;132:182–5.
- Yamanaka A. Morphopathology of chronic pulmonary emphysema. Acta Pathol Jpn 1965;15:33–9.
- Fujimoto K, Ikeda S, Arai T, Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy cases. BMC Med Genet 2010;11:159–65.
- Wright JL, Thurlbeck WM, editors. Emphysema: classification, morphology, and associations. Thurlbeck's Chronic Airflow Obstruction. 2nd ed. Hamilton (ON): B.C. Decker, Inc.; 1999. Chapter 4; p. 85–144.
- Myers JL. Thurlbeck's pathology of the lung. 3rd ed. New York: Thieme Medical Publishers, Inc.; 2005. Chapter 20, Idiopathic interstitial pneumonias; p. 563–600.
- Myers JL. Other diffuse lung diseases. Thurlbeck's Pathology of the Lung. 3rd ed. Wright JL, Thurlbeck WM, editors. New York: Thieme Medical Publishers, Inc., 2005; Chapter 21; pp. 601–74.
- Holland PM, Abramson RD, Watson R, Detection of specific polymerase chain reaction product by utilizing the 52–32 exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991;88:7276–80.
- Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173–82.
- Wang J, Spitz MR, Amos CI, Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer 2010;116:3458–62.
- Kenny DA, Kashy DA, Bolger N. Data analysis in social psycho-logy. The Handbook of Social Psychology. Gilbert DT, Fiske ST, Lindzey G, editors. Boston: McGraw-Hill; 1998; p. 233–65.
- MacKinnon A. Estimating mediated effects in prevention studies. Eval Rev 1993;17:144–58.
- Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput 2004;36:717–31.
- Raghu G, Collard HR, Egan JJ, ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788–824.
- Leth-Larsen R, Garred P, Jensenius H, A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 2005;174:1532–8.
- Sorensen GL, Hoegh SV, Leth-Larsen R, Multimeric and trimeric subunit SP-D are interconvertible structures with distinct ligand interaction. Mol Immunol 2009;46:3060–9.
- Shiels MS, Chaturvedi AK, Katki HA, Circulating markers of interstitial lung disease and subsequent risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2011;20:2262–72.
- de Gracia J, Mata F, Alvarez A, Genotype-phenotype correlation for pulmonary function in cystic fibrosis. Thorax 2005;60:558–63.
- Cohen JC, Kiss RS, Pertsemlidis A, Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004;305:869–72.
- Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003;18:377–85.
- Ligtenberg AJ, Veerman EC, Nieuw Amerongen AV, Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol Chem 2007;388:1275–89.
- Wu W, Kemp BL, Proctor ML, Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer. Cancer Res 1999;59:1846–51.
- Bridges JP, Wert SE, Nogee LM, Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem 2003;278:52739–46.
- Mulugeta S, Nguyen V, Russo SJ, A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am J Respir Cell Mol Biol 2005;32:521–30.